SAGE
$12.89
Revenue | $77.97Mn |
Net Profits | $-32.71Mn |
Net Profit Margins | -41.95% |
Sage Therapeutics Inc’s revenue jumped 2621.54% since last year same period to $77.97Mn in the Q4 2023. On a quarterly growth basis, Sage Therapeutics Inc has generated 2770.84% jump in its revenue since last 3-months.
Sage Therapeutics Inc’s net profit jumped 75.47% since last year same period to $-32.71Mn in the Q4 2023. On a quarterly growth basis, Sage Therapeutics Inc has generated 83.78% jump in its net profits since last 3-months.
Sage Therapeutics Inc’s net profit margin jumped 99.1% since last year same period to -41.95% in the Q4 2023. On a quarterly growth basis, Sage Therapeutics Inc has generated 99.43% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -1.65 |
EPS Estimate Current Year | -1.65 |
Sage Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -1.65 - a -28.91% fall from last quarter’s estimates.
Sage Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -1.65.
Earning Per Share (EPS) | -1.8 |
Return on Assets (ROA) | -0.31 |
Return on Equity (ROE) | -0.53 |
Sage Therapeutics Inc’s earning per share (EPS) jumped 27.13% since last year same period to -1.8 in the Q4 2023. This indicates that the Sage Therapeutics Inc has generated 27.13% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Sage Therapeutics Inc’s return on assets (ROA) stands at -0.31.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Sage Therapeutics Inc’s return on equity (ROE) stands at -0.53.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-11-07 | -2.73 | -3.37 | -23.44% |
2023-08-07 | -2.55 | -2.68 | -5.1% |
2024-02-14 | -1.28 | -1.8 | -40.63% |
2023-05-02 | -2.5 | -2.46 | 1.6% |